What it sells
BioConsortia develops microbial biological inputs for crops in nitrogen fixation, biocontrol and biostimulants, designed primarily for seed application, using its microbe discovery and genetic optimization platform.
Business model breakdown
Distribution: how it reaches customers
Commercialized through strategic partners and select market channels.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-10-15 | — | $15M | — | pulse2.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-17.